Angelika Buczyńska

Medical University of Białystok
Country flagPoland

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (17)

Context Papillary thyroid cancer (PTC) aggressiveness and metastatic potential are closely associated with angioinvasion. Identifying angioinvasion accurately is imperative for treatment planning and prognosis. Objective This study explores serum biomarkers, including 8-hydroxydeoxyguanosine (8-OHdG) and oxidative status markers (total oxidative capacity, total antioxidant capacity [TAC], and sortilin), as potential indicators of angioinvasion in PTC. Design A cross-sectional study involving 50 angioinvasive patients with PTC (study group) and 30 patients with PTC with low-risk features (reference group). Serum levels of biomarkers were analyzed to determine their association with angioinvasion. Setting Patients were recruited from Department of Endocrinology, Diabetology, and Internal Diseases, Medical University of Bialystok, Poland, ensuring representation from a diverse clinical context. Patients or Other Participants Participants included patients with PTC, with 50 in the study group and 30 in the reference group. Selection criteria, matching characteristics, and participant completion rates were duly recorded. Intervention(s) Serum biomarkers were measured to evaluate their association with PTC angioinvasion. Main Outcome Measure(s) Primary outcome measures included serum levels of 8-OHdG, total oxidative capacity, TAC, and sortilin. Results Serum levels of 8-OHdG and sortilin were significantly elevated in angioinvasive PTC, whereas TAC showed a notable decrease (all P < .01). A regression panel combining TAC, 8-OHdG, and sortilin demonstrated a high area under the curve value (0.963) for angioinvasion discernment. Conclusion Measuring TAC, 8-OHdG, and sortilin levels may serve as potential biomarkers for identifying angioinvasion in PTC. The combined assessment of these biomarkers enhances angioinvasion discernment, aiding risk stratification and personalized treatment decisions. Further validation studies are required before integrating these biomarkers into routine clinical practice. The study adheres to the provided structure, providing concise and supported conclusions based on the results.

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (9)

Joanna Konopińska

Medical University of Bialystok

POLAND
View details

Diana Dmuchowska

Medical University of Białystok

POLAND
View details

Michal Ciborowski

Medical University of Białystok

POLAND
View details

Urszula Miksza

Medical University of Białystok

POLAND
View details

Adam Jacek Krętowski

Medical University of Bialystok

POLAND
View details

Irina Kowalska

Head of the department/prof

Medical University of Białystok

POLAND
View details

Anna Popławska-Kita

Medical University of Bialystok

POLAND
View details

Agnieszka Adamska

Medical University of Białystok

POLAND
View details

Magdalena Niemira

Assistant Professor

Medical University of Bialystok

POLAND
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.